Emma Kavanagh

861 total citations
17 papers, 611 citations indexed

About

Emma Kavanagh is a scholar working on Molecular Biology, Cell Biology and Rheumatology. According to data from OpenAlex, Emma Kavanagh has authored 17 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cell Biology and 5 papers in Rheumatology. Recurrent topics in Emma Kavanagh's work include Osteoarthritis Treatment and Mechanisms (5 papers), Proteoglycans and glycosaminoglycans research (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Emma Kavanagh is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (5 papers), Proteoglycans and glycosaminoglycans research (5 papers) and Glycosylation and Glycoproteins Research (3 papers). Emma Kavanagh collaborates with scholars based in United Kingdom, Ireland and United States. Emma Kavanagh's co-authors include Doreen E. Ashhurst, Karl Matter, María S. Balda, Sinéad Lindsay, Amanda McCann, Andrew A. Pitsillides, Paul Dowling, Christopher J. Marshall, Ami Aronheim and Tom D. Bunney and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Chemical Communications.

In The Last Decade

Emma Kavanagh

17 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Kavanagh United Kingdom 14 409 146 94 89 70 17 611
Cristina Vanni Italy 13 297 0.7× 128 0.9× 120 1.3× 30 0.3× 83 1.2× 24 624
Shamik Das United States 15 475 1.2× 64 0.4× 157 1.7× 46 0.5× 259 3.7× 22 775
Irwan T. Makagiansar United States 13 419 1.0× 141 1.0× 64 0.7× 18 0.2× 123 1.8× 17 753
Ken Matsumoto Japan 16 484 1.2× 135 0.9× 82 0.9× 10 0.1× 110 1.6× 29 685
Eleonora Presman United States 9 470 1.1× 99 0.7× 61 0.6× 22 0.2× 67 1.0× 10 640
Karine Landry Canada 9 385 0.9× 165 1.1× 35 0.4× 20 0.2× 27 0.4× 9 575
Takashi Shirakawa Japan 7 466 1.1× 99 0.7× 75 0.8× 14 0.2× 70 1.0× 12 671
Martina Schwarzkopf United States 8 526 1.3× 97 0.7× 25 0.3× 32 0.4× 96 1.4× 8 699
Jennifer L. Northrop United States 14 543 1.3× 125 0.9× 46 0.5× 45 0.5× 47 0.7× 16 784
Hideo Takeshima Japan 13 219 0.5× 45 0.3× 69 0.7× 18 0.2× 166 2.4× 18 512

Countries citing papers authored by Emma Kavanagh

Since Specialization
Citations

This map shows the geographic impact of Emma Kavanagh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Kavanagh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Kavanagh more than expected).

Fields of papers citing papers by Emma Kavanagh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Kavanagh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Kavanagh. The network helps show where Emma Kavanagh may publish in the future.

Co-authorship network of co-authors of Emma Kavanagh

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Kavanagh. A scholar is included among the top collaborators of Emma Kavanagh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Kavanagh. Emma Kavanagh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Krstić, Aleksandar, Cristina Casalou, Nora Rauch, et al.. (2023). Kinase Suppressor of RAS 1 (KSR1) Maintains the Transformed Phenotype of BRAFV600E Mutant Human Melanoma Cells. International Journal of Molecular Sciences. 24(14). 11821–11821. 5 indexed citations
2.
Kavanagh, Emma, Melinda Halász, Paul Dowling, et al.. (2020). N -Linked glycosylation profiles of therapeutic induced senescent (TIS) triple negative breast cancer cells (TNBC) and their extracellular vesicle (EV) progeny. Molecular Omics. 17(1). 72–85. 14 indexed citations
3.
Kavanagh, Emma, Shane O’Grady, Alex J. Eustace, et al.. (2020). The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cells. Investigational New Drugs. 39(2). 587–594. 21 indexed citations
4.
Ho, Matthew, Emma Kavanagh, Paul Dowling, et al.. (2019). Targeting Proteotoxic Stress in Cancer: A Review of the Role that Protein Quality Control Pathways Play in Oncogenesis. Cancers. 11(1). 66–66. 89 indexed citations
5.
MacSharry, John, Yensi Flores Bueso, Sinéad Lindsay, et al.. (2018). Resident bacteria in breast cancer tissue: pathogenic agents or harmless commensals?. PubMed. 26(142). 93–102. 22 indexed citations
6.
Kavanagh, Emma, Sinéad Lindsay, Melinda Halász, et al.. (2017). Protein and chemotherapy profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells. Oncogenesis. 6(10). e388–e388. 80 indexed citations
7.
Bell, Stephen G., et al.. (2012). Tailoring an alien ferredoxin to support native-like P450 monooxygenase activity. Chemical Communications. 48(95). 11692–11692. 31 indexed citations
8.
Kavanagh, Emma, Michael Büchert, Anna Tsapara, et al.. (2006). Functional interaction between the ZO-1-interacting transcription factor ZONAB/DbpA and the RNA processing factor symplekin. Journal of Cell Science. 119(24). 5098–5105. 59 indexed citations
9.
Bastow, Edward, et al.. (2005). Selective Activation of the MEK-ERK Pathway Is Regulated by Mechanical Stimuli in Forming Joints and Promotes Pericellular Matrix Formation. Journal of Biological Chemistry. 280(12). 11749–11758. 46 indexed citations
10.
Frankel, Paul, Ami Aronheim, Emma Kavanagh, et al.. (2004). RalA interacts with ZONAB in a cell density‐dependent manner and regulates its transcriptional activity. The EMBO Journal. 24(1). 54–62. 91 indexed citations
11.
Lewthwaite, Jo, et al.. (2003). Diverse range of fixed positional deformities and bone growth restraint provoked by flaccid paralysis in embryonic chicks. International Journal of Experimental Pathology. 84(4). 191–199. 36 indexed citations
12.
Kavanagh, Emma, et al.. (2002). DIVISION AND DEATH OF CELLS IN DEVELOPING SYNOVIAL JOINTS AND LONG BONES. Cell Biology International. 26(8). 679–688. 29 indexed citations
13.
Kavanagh, Emma, et al.. (2002). Keratan Sulfate Epitopes Exhibit a Conserved Distribution During Joint Development That Remains Undisclosed on the Basis of Glycosaminoglycan Charge Density. Journal of Histochemistry & Cytochemistry. 50(8). 1039–1047. 14 indexed citations
14.
Smith, Ryan P., Emma Kavanagh, Hilary G. Morrison, & Robert M. Gould. (2001). Messenger RNAs Located in Spiny Dogfish Oligodendrocyte Processes. Biological Bulletin. 201(2). 255–256. 3 indexed citations
15.
Kavanagh, Emma & Doreen E. Ashhurst. (2001). Distribution of Biglycan and Decorin in Collateral and Cruciate Ligaments and Menisci of the Rabbit Knee Joint. Journal of Histochemistry & Cytochemistry. 49(7). 877–885. 13 indexed citations
16.
Kavanagh, Emma & Doreen E. Ashhurst. (1999). Development and Aging of the Articular Cartilage of the Rabbit Knee Joint: Distribution of Biglycan, Decorin, and Matrilin-1. Journal of Histochemistry & Cytochemistry. 47(12). 1603–1615. 41 indexed citations
17.
Coleman, P. G., Emma Kavanagh, Roger M. Mason, J. R. Levick, & Doreen E. Ashhurst. (1998). The Proteoglycans and Glycosaminoglycan Chains of Rabbit Synovium. The Histochemical Journal. 30(7). 519–524. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Vanni Breakdown of academic impact, for papers by Shamik Das Breakdown of academic impact, for papers by Irwan T. Makagiansar Breakdown of academic impact, for papers by Ken Matsumoto Breakdown of academic impact, for papers by Eleonora Presman Breakdown of academic impact, for papers by Karine Landry Breakdown of academic impact, for papers by Takashi Shirakawa Breakdown of academic impact, for papers by Martina Schwarzkopf Breakdown of academic impact, for papers by Jennifer L. Northrop Breakdown of academic impact, for papers by Hideo Takeshima
Rankless by CCL
2026